1Begg AC,Mcnally NJ,Shreive DC,et al.method to measure the duration of the DNA synthesis and potential doubling time from a single sample.Cytometry,1985,6:620-626.
2Speke AK,Hill RP.Repopulation kinetics during fractionated irradiation and the relationship to the potential doubling time,Tpot.Int J Radiat Oncol Biol Phys,1995,31:847-856.
3Haustermans K,Hofland I,Pottic G,et al.Can measurements of potential doubling time(Tpot)be compared between laboratories? A quality control Cytometry,1995,19:154-163.
5Sasaki K,Takashi M.Preservation of cell cycle characteristics in solid tumour in vitro.Cancer Res,1980,40:4810-4812.
6Kamata T,Yoneura Y,Sugiama K,et al.Proliferation activity of early gastric cancer measured by in vitro and in vivo bromodeoxyuridine labelling.Cancer,1989,64:1665-1668.
7Wilson GD,Mcnally NJ,Dunphy E,et al.The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytomctry.Cytometry.1985,6:641-647.
8Chavaudra N,Richard JM,Malaise EP.Labelling index of human squamous cell carcinomas.Cell Tissue Kinet,1979,12:145-152.
2Horiot JC, Bontemps P, Van den Bogaert W, et al. Accelerated fractionation compared to conventional fractionation im-proves locoregional control in the radiotherapy of advanced head and neck cancers:Besults of the EOBTC 22851 randomized trial. Badiother Oncol, 1997,44 : 111-121.
3Dische S, Saundevs M, Barrett A, et al. A randomized multicentre trial of CHART versus conventional radiotherapy for head and neck cancer. Radiother Oncol, 1997,44 : 123-136.
4Withers RH,Taylor JMG, Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol, 1988,27 : 131-146.
5Saunders M, Dische S, Barrett A, et al. Continuous, hyperfractionated,accelerated radiotherapy(CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. Radiother Oncol, 1999,52 : 137-148.
6Cox JD, Pajak TF, Asbel AH, et al. Interruption of high-dose radiation therapy decrease long-term survival of favorable patients with unrespectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 RTOG trials. Int J Radiat Oncol Biol Phys, 1993,27:493-498.
7Tarnawski R, Fowler J, Sldadowski K, et al. How fast is repopulation of tumor cells during the treatment gap? Int J Radiat Oncol Biol Phys,2002,54:229-236.
8Maciejewski B,Sldadowski K,Pilecki B,et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol, 1996,40 : 137-145.
9van der Schueren E,van der Bogaert W,Vanuytsel L,et al. Radiotherapy by multiple fractions per day ( MFD ) in head and neck cancer: acute reactions of skin and mucosa. Int J Radiat Oncol Biol Phys, 1990,19:301-311.
10Skladowski K,Maciejewski B ,Golen M ,et al. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year turnout control and normal tissue toxicity. Radiother Oncol,2000,55 : 101-110.
